Key facts: J.P. Morgan analyst Brian Essex doubts the positive market response to IBM's stock, noting that bond-trading study results may not be repeatable outside a research setting.
Bacaan kurang dari 1 minit
- J.P. Morgan analyst Brian Essex doubts the positive market response to IBM's stock, noting that bond-trading study results may not be repeatable outside a research setting.1
- IBM has expanded its partnership with AWS to boost cloud use and digital change in the Middle East, targeting e-government, healthcare, and banking sectors.2